Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Wednesday, May 27, 2020.

Zynerba Pharmaceuticals (NASDAQ:ZYNE)

Long-Term Uptrend (+90) - ZYNE is in a strong uptrend that is likely to continue. While ZYNE is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.

Is it time to buy, sell, or avoid ZYNE?

MarketClub looks at technical strength and momentum to determine if the timing is right for ZYNE.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

NASDAQ_ZYNE
Open High Low ZYNE Price Change
6.33 6.43 5.50 5.57 -0.62
Entry Signal

MarketClub’s Trade Triangles for ZYNE

long term up The long-term trend has been UP since May 21st, 2020 at 5.45

intermediate term up The intermediate-term trend has been UP since Apr 27th, 2020 at 4.18

short term up The short-term trend has been UP since May 18th, 2020 at 4.34

Smart Scan Analysis for ZYNE

Based on our trend formula, ZYNE is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

+90
Smart Scan Analysis for ZYNE
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
6.33 6.43 5.50 5.57 -0.62
Prev. Close Volume Bid Ask Time
3.67 3349160 2020-05-27 15:59:58
Year High14.45Year High Date2018-01-03
Year Low4.5Year Low Date2018-11-28
52wk High16.4752wk High Date2019-05-17
52wk Low2.5552wk Low Date2020-03-17
Average Volume560,460Shares Outstanding23,556
Market Cap283MAssets87,764,596M
Liabilities12,167,853MP/E Ratio-1.30903
Volatility78.39
Get a free daily analysis and signals for Zynerba Pharmaceuticals (ZYNE) - Request Your Free Report.